Listen to the article
Nine Oklahoma pharmacies will pay $157,000 to resolve allegations of fraudulently billing the state’s Medicaid program for unauthorized COVID-19 tests, according to a settlement announced by state officials on Tuesday.
The pharmacies, including Apothecary Pharmacy, Cornwell Pharmacy, Cushing Family Pharmacy, R.T.’s Family Discount Pharmacy, Foster Corner Drug, Tiger Drug, Yale Drug, Jones Drug Store, and Swipht Pharmacy, were investigated by the Oklahoma Attorney General’s Medicaid Fraud Control Unit for submitting claims to SoonerCare for hundreds of over-the-counter COVID-19 tests that weren’t approved for reimbursement.
“I appreciate the careful and extensive work by my investigative team to recover these funds,” Attorney General Gentner Drummond said in a statement. “I take seriously all allegations of false claims and am committed to holding anyone who abuses the system accountable to the law.”
The case highlights ongoing challenges in Medicaid program integrity during the pandemic era. When COVID-19 testing became widely available through retail channels, complex reimbursement rules governed which tests qualified for Medicaid coverage. According to healthcare compliance experts, confusion about billing guidelines for pandemic-related services has led to numerous investigations nationwide.
The Oklahoma investigation comes amid increased scrutiny of pandemic-related healthcare billing across the country. Federal authorities have prioritized identifying and prosecuting cases of COVID-19 relief fraud, including improper billing for testing, treatment, and vaccination services.
This settlement represents one of several recent enforcement actions targeting alleged healthcare fraud in Oklahoma. The state’s Medicaid Fraud Control Unit has ramped up investigations into various healthcare providers since the pandemic began, reflecting a nationwide trend of increased oversight of pandemic-related healthcare spending.
For many independent pharmacies already operating on thin margins, settlements like this can have significant financial impacts. Industry analysts note that independent pharmacies nationwide have faced mounting challenges in recent years, including reduced reimbursement rates, increased competition from mail-order services, and complex regulatory compliance requirements.
The investigation was led by Assistant Attorney General Jamie Bloyd with Agents Justin Brown and Daniel Shcolnik. The settlement agreement does not require the pharmacies to admit wrongdoing, which is typical in such cases.
SoonerCare, Oklahoma’s Medicaid program, provides healthcare coverage to approximately one million low-income residents, including children, pregnant women, and people with disabilities. The program has expanded significantly in recent years following Medicaid expansion in the state.
The Oklahoma Attorney General’s Office Medicaid Fraud Control Unit operates primarily on federal funding, receiving 75 percent of its $6.35 million annual budget from the U.S. Department of Health and Human Services. The remaining 25 percent comes from state funds. This federal-state partnership model is standard for Medicaid fraud control units across the country.
Healthcare providers who suspect Medicaid fraud are encouraged to report it to the state’s Medicaid Fraud Control Unit. Whistleblowers are protected under state and federal laws from retaliation for reporting suspected fraud or improper billing practices.
As healthcare delivery continues to evolve in the aftermath of the pandemic, compliance experts emphasize the importance of thorough documentation and strict adherence to billing guidelines, particularly for services related to public health emergencies where reimbursement rules may change rapidly.
Verify This Yourself
Use these professional tools to fact-check and investigate claims independently
Reverse Image Search
Check if this image has been used elsewhere or in different contexts
Ask Our AI About This Claim
Get instant answers with web-powered AI analysis
Related Fact-Checks
See what other fact-checkers have said about similar claims
Want More Verification Tools?
Access our full suite of professional disinformation monitoring and investigation tools
16 Comments
The alleged actions of these Oklahoma pharmacies, if true, represent a clear abuse of the Medicaid system. I’m glad to see the state Attorney General pursuing this case to recover funds and hold the providers accountable.
Maintaining program integrity is crucial, especially during challenging times like the pandemic. Enforcement actions like this one help deter future fraudulent activity.
While the pandemic has presented complexities for Medicaid reimbursement, that’s no excuse for pharmacies to allegedly submit claims for unauthorized tests. It’s good to see the state Attorney General taking action to protect program integrity.
A $157,000 settlement seems like an appropriate penalty to discourage similar fraudulent behavior in the future.
This case highlights the ongoing challenges in Medicaid program integrity during the pandemic. It’s good to see the Oklahoma Attorney General’s office taking action against pharmacies that allegedly abused the system through unauthorized COVID-19 test claims.
Holding providers accountable for false claims is important to protect the integrity of public healthcare programs like Medicaid.
Interesting to see the nuances around Medicaid reimbursement for COVID-19 tests during the pandemic. It’s understandable that the rules were complex, but pharmacies need to play by the rules to avoid allegations of fraud.
I hope the settlement amount of $157,000 serves as an adequate deterrent against similar abuses in the future.
This case underscores the importance of clear Medicaid reimbursement rules, especially for new healthcare services like COVID-19 testing that emerged during the pandemic. Providers need to carefully follow the guidelines to avoid allegations of false claims.
Kudos to the investigators for uncovering this abuse and recovering funds for the Medicaid program.
This settlement highlights the ongoing challenges Medicaid programs face in ensuring proper billing and reimbursement, especially for new services like COVID-19 testing. Pharmacies need to be diligent in following the rules to avoid allegations of false claims.
I hope this case serves as a lesson to other providers that Medicaid fraud will be investigated and prosecuted, even during the pandemic.
As the healthcare compliance expert mentioned, the pandemic era has presented ongoing challenges for Medicaid program integrity. This case highlights the importance of clear reimbursement guidelines and strong enforcement to prevent fraud.
Kudos to the Oklahoma Attorney General’s Medicaid Fraud Control Unit for their diligent investigation and recovery of funds.
The alleged actions of these nine Oklahoma pharmacies, if true, are quite concerning. Submitting claims for unauthorized COVID-19 tests is a clear abuse of the Medicaid system that needs to be addressed.
It’s good to see the Attorney General taking this seriously and holding the pharmacies accountable through this settlement.